Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01692574 · ClinicalTrials.gov registry record · NA
Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT01692574: Completed NA study, sponsored by University of Pennsylvania.
NCT01692574 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 76 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01692574, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
To determine whether individuals who suffer from depression and obesity are able to lose weight and show improvements in mood and cardiovascular disease risk factors following 20 weeks of a combined treatment of cognitive-behavior therapy for depression and behavior modification for weight loss. Participants will be assigned to one of three treatments: 1) cognitive-behavior therapy for the treatment of depression combined with an alternative approach to weight loss, 2) a weight loss intervention combined with a depression support and education , or 3) cognitive-behavioral therapy for depression combined with a weight loss intervention.
Primary Outcome
To determine whether depressed, obese individuals who receive the combined treatment of cognitive-behavior therapy for depression and behavior modification for weight loss are able to lose 5% of their initial weight at the end of 20 weeks of treatment.
Interventions
- BEHAVIORAL Behavior Modification for Weight Loss
- BEHAVIORAL Alternative Approach to Weight Loss
- BEHAVIORAL Cognitive-Behavior Therapy for Depression
- BEHAVIORAL Depression Support and Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-11 |
| Phase | NA |
What the finished NCT01692574 record still lists
NCT01692574 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which Behavior Modification for Weight Loss is the first listed.
NCT01692574 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01692574 about?
NCT01692574 is a clinical study titled "Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)". To determine whether individuals who suffer from depression and obesity are able to lose weight and show improvements in mood and cardiovascular disease risk factors following 20 weeks of a combined treatment of cognitive-behavior therapy for depression and behavior modification for weight loss. Par...
What is the current status of trial NCT01692574?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2012-08. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01692574?
The interventions under investigation include: Behavior Modification for Weight Loss (BEHAVIORAL), Alternative Approach to Weight Loss (BEHAVIORAL), Cognitive-Behavior Therapy for Depression (BEHAVIORAL), Depression Support and Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01692574?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01692574's enrollment target sits among peer trials
76 1062nd of 2000 higher than 932 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia